Metformin use doesn't cut incidence of bladder cancer

Metformin use doesn't cut incidence of bladder cancer

(HealthDay)—For patients with type 2 diabetes, metformin use is not associated with a significantly reduced risk of bladder cancer, according to a study published online Feb. 4 in Diabetes Care.

Ronac Mamtani, M.D., from the University of Pennsylvania in Philadelphia, and colleagues conducted a involving 87,600 patients with in The Health Improvement Network database. The incidence of in new users of and sulfonylureas was examined. Metformin or sulfonylurea use was treated as a time-dependent variable. The authors hoped to address the time-related biases that may have affected previous studies relating to the effect of metformin on cancer risk.

The researchers identified 196 incident bladder cancers in the metformin cohort and 66 in the sulfonylurea cohort. The risk of bladder cancer was not significantly decreased in association with metformin use (hazard ratio, 0.81; 95 percent confidence interval [CI], 0.60 to 1.09). The correlation was not affected by sex (P for interaction = 0.20). There was also no reduction in bladder cancer risk with increased duration of metformin use relative to use of sulfonylureas (three to less than four years of use: 0.57 [95 percent CI, 0.25 to 1.34]; four to less than five years of use: 0.93 [95 percent CI, 0.30 to 2.85]; and five or more years of use: 1.18 [95 percent CI, 0.44 to 3.19]; P for trend = 0.26).

"Similar methods should be used to study other cancers that have previously been identified as potentially preventable with metformin," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.


Explore further

Post-breast cancer, metformin has no effect on mortality

More information: Abstract
Full Text (subscription or payment may be required)
Journal information: Diabetes Care

Copyright © 2014 HealthDay. All rights reserved.

Citation: Metformin use doesn't cut incidence of bladder cancer (2014, February 11) retrieved 15 September 2019 from https://medicalxpress.com/news/2014-02-metformin-doesnt-incidence-bladder-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more